News
-
-
-
PRESS RELEASE
83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Jaguar Health's Canalevia-CA1 receives FDA approval for chemotherapy-induced diarrhea in dogs, addressing a critical unmet need in veterinary oncology -
-
PRESS RELEASE
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies to feature interviews with bioAffinity Technologies, Inc. and Can-Fite BioPharma Ltd. on Bloomberg TV's Small Stocks, Big Money™ show this Saturday. Companies discuss innovative therapies and milestones -
-
-
-
PRESS RELEASE
Two of LQR House Stockholders, Including Its CEO, Enter Lock-up Agreement Covering at Least 209,543 Shares
LQR House Inc. announced 12-month lock-up agreements signed by stockholders including its CEO to cover 209,543 shares, promoting market stability for the alcohol e-commerce platform -
